This is the sixth edition of the National Essential Medicines List coming six years after the last revision in 2010. The process adopted in this revision has largely followed the 2001 revised procedure for updating WHO’s Model List of Essential Medicines.
Essentially the procedure for production of this list followed the initial revision of the Standard Treatment Guidelines and extensive consultation with all stakeholders including the Public Health programmes.
It is intended that prudent use of the medicines in the list will foster rational, safe and cost-effectiveness in the provision of health care. In order to ensure more inclusiveness, comprehensiveness and use by all levels of the healthcare system, notice has been taken of a broadened scope of medicines for treatment of diseases at higher levels of care.